Show simple item record

dc.contributor.authorDaye, Dania
dc.contributor.authorTabari, Azadeh
dc.contributor.authorKim, Hyunji
dc.contributor.authorChang, Ken
dc.contributor.authorKamran, Sophia C.
dc.contributor.authorHong, Theodore S.
dc.contributor.authorKalpathy-Cramer, Jayashree
dc.contributor.authorGee, Michael S.
dc.date.accessioned2022-02-07T15:51:11Z
dc.date.available2021-11-01T14:33:57Z
dc.date.available2022-02-07T15:51:11Z
dc.date.issued2021-01
dc.date.submitted2020-11
dc.identifier.issn0938-7994
dc.identifier.issn1432-1084
dc.identifier.urihttps://hdl.handle.net/1721.1/136879.2
dc.description.abstractAbstract Objectives Intra-tumor heterogeneity has been previously shown to be an independent predictor of patient survival. The goal of this study is to assess the role of quantitative MRI-based measures of intra-tumor heterogeneity as predictors of survival in patients with metastatic colorectal cancer. Methods In this IRB-approved retrospective study, we identified 55 patients with stage 4 colon cancer with known hepatic metastasis on MRI. Ninety-four metastatic hepatic lesions were identified on post-contrast images and manually volumetrically segmented. A heterogeneity phenotype vector was extracted from each lesion. Univariate regression analysis was used to assess the contribution of 110 extracted features to survival prediction. A random forest–based machine learning technique was applied to the feature vector and to the standard prognostic clinical and pathologic variables. The dataset was divided into a training and test set at a ratio of 4:1. ROC analysis and confusion matrix analysis were used to assess classification performance. Results Mean survival time was 39 ± 3.9 months for the study population. A total of 22 texture features were associated with patient survival (p < 0.05). The trained random forest machine learning model that included standard clinical and pathological prognostic variables resulted in an area under the ROC curve of 0.83. A model that adds imaging-based heterogeneity features to the clinical and pathological variables resulted in improved model performance for survival prediction with an AUC of 0.94. Conclusions MRI-based texture features are associated with patient outcomes and improve the performance of standard clinical and pathological variables for predicting patient survival in metastatic colorectal cancer. Key Points • MRI-based tumor heterogeneity texture features are associated with patient survival outcomes. • MRI-based tumor texture features complement standard clinical and pathological variables for prognosis prediction in metastatic colorectal cancer. • Agglomerative hierarchical clustering shows that patient survival outcomes are associated with different MRI tumor profiles.en_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.relation.isversionofhttps://doi.org/10.1007/s00330-020-07673-0en_US
dc.rightsArticle is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.en_US
dc.sourceSpringer Berlin Heidelbergen_US
dc.titleQuantitative tumor heterogeneity MRI profiling improves machine learning–based prognostication in patients with metastatic colon canceren_US
dc.typeArticleen_US
dc.contributor.departmentMassachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
dc.relation.journalEuropean Radiologyen_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2021-07-10T03:17:37Z
dc.language.rfc3066en
dc.rights.holderEuropean Society of Radiology
dspace.embargo.termsY
dspace.date.submission2021-07-10T03:17:37Z
mit.journal.volume31en_US
mit.journal.issue8en_US
mit.licensePUBLISHER_POLICY
mit.metadata.statusAuthority Work Neededen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

VersionItemDateSummary

*Selected version